{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:45:44Z","timestamp":1791841544239,"version":"4.3.4"},"reference-count":51,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2019,11,25]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The process of antigen presentation to immune cells is an undeniable contributor\nto the pathogenesis of autoimmune diseases. Different studies have indicated several factors\nthat are related to autoimmunity. Human Leukocyte Antigens (HLAs) are among such factors,\nwhich have a key role in autoimmunity because of their involvement in antigen presentation process.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Relevant English language literature was searched and retrieved from Google Scholar\nsearch engine and PubMed database (1996-2018). The following keywords were used: \"Human\nleukocyte antigen\", \"Behcet\u2019s syndrome\", \"Rheumatoid arthritis\", \"Systemic lupus erythematosus\",\n\"Type 1 diabetes\", \"Celiac Disease\" and \"Autoimmunity\".<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>There is a strong association between HLA alleles and autoimmune diseases. For instance,\nHLA-B alleles and Behcet\u2019s syndrome are strongly correlated, and systemic lupus erythematosus\nand Type 1 diabetes are related to HLA-DQA1 and HLA-DQB1, respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Association between numerous HLA alleles and autoimmune diseases may justify and\nrationalize their use as biomarkers as well as possible diagnostic laboratory parameters.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573397115666190115143226","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T05:53:25Z","timestamp":1547531605000},"page":"269-276","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["HLAs in Autoimmune Diseases: Dependable Diagnostic Biomarkers?"],"prefix":"10.2174","volume":"15","author":[{"given":"Elham","family":"Rajaei","sequence":"first","affiliation":[{"name":"Golestan Hospital Clinical Research Development Unit, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Taha","family":"Jalali","sequence":"additional","affiliation":[{"name":"Hyperlipidemia Research Center, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Shahrabi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Hematology, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Amin","family":"Asnafi","sequence":"additional","affiliation":[{"name":"Thalassemia & Hemoglobinopathy Research center, Health research institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad Sadegh","family":"Pezeshki","sequence":"additional","affiliation":[{"name":"Thalassemia & Hemoglobinopathy Research center, Health research institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.yfrne.2014.04.004","volume":"35","author":"Ngo S.T.","year":"2014","unstructured":"Ngo S.T.; Steyn F.J.; McCombe P.A.; Gender differences in autoimmune disease. Front Neuroendocrinol 2014,35(3),347-369","journal-title":"Front Neuroendocrinol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0092-8674(00)81110-1","volume":"85","author":"Vyse T.J.","year":"1996","unstructured":"Vyse T.J.; Todd J.A.; Genetic analysis of autoimmune disease. Cell 1996,85(3),311-318","journal-title":"Cell"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/90935","volume":"7","author":"Marrack P.","year":"2001","unstructured":"Marrack P.; Kappler J.; Kotzin B.L.; Autoimmune disease: why and where it occurs. Nat Med 2001,7(8),899-905","journal-title":"Nat Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/art.1780371002","volume":"37","author":"Mountz J.D.","year":"1994","unstructured":"Mountz J.D.; Wu J.; Cheng J.; Zhou T.; Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 1994,37(10),1415-1420","journal-title":"Arthritis Rheum"},{"key":"ref=5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000024","volume":"4","author":"Fernando MM","year":"2008","unstructured":"Fernando MM; Stevens CR; Walsh EC; Defining the role of\nthe MHC in autoimmunity: a review and pooled analysis. PLoS Genet 2008,4(4)","journal-title":"PLoS Genet"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.gdata.2016.11.012","volume":"11","author":"Shahsavar F.","year":"2016","unstructured":"Shahsavar F.; Varzi A-M.; Ahmadi S.A.Y.; A genomic study on distribution of human leukocyte antigen (HLA)-A and HLA-B alleles in Lak population of Iran. Genom Data 2016,11,3-6","journal-title":"Genom Data"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40744-018-0100-z","volume":"5","author":"Bodis G.","year":"2018","unstructured":"Bodis G.; Toth V.; Schwarting A.; Role of Human Leukocyte Antigens (HLA) in autoimmune diseases. Rheumatol Ther 2018,5(1),5-20","journal-title":"Rheumatol Ther"},{"key":"ref=8","first-page":"40","volume":"7","author":"Ahmadzadeh A.","year":"2013","unstructured":"Ahmadzadeh A.; Saedi S.; Jaseb K.; Asnafi A.A.; Alghasi A.; Saki N.; T-cell acute lymphoblastic leukemia with del (7)(q11. 2q22) and aberrant expression of myeloid markers. Int J Hematol Oncol Stem Cell Res 2013,7(4),40-44","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"ref=9","author":"Asnafi A.A.","year":"2018","unstructured":"Asnafi A.A.; Jalali M.T.; Pezeshki S.M.S.; Jaseb K.; Saki N.; The Association Between Human Leukocyte Antigens and ITP, TTP, and HIT. J Pediatr Hematol Oncol 2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/iji.12088","volume":"41","author":"Howell W.M.","year":"2014","unstructured":"Howell W.M.; HLA and disease: guilt by association. Int J Immunogenet 2014,41(1),1-12","journal-title":"Int J Immunogenet"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/jhg.2015.100","volume":"60","author":"Miyadera H.","year":"2015","unstructured":"Miyadera H.; Tokunaga K.; Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism. J Hum Genet 2015,60(11),697-702","journal-title":"J Hum Genet"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/1756-185X.12691","volume":"19","author":"Davatchi F.","year":"2016","unstructured":"Davatchi F.; Chams-Davatchi C.; Shams H.; Adult Behcet\u2019s disease in Iran: analysis of 6075 patients. Int J Rheum Dis 2016,19(1),95-103","journal-title":"Int J Rheum Dis"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2016.202","author":"Ryu H.J.","year":"2017","unstructured":"Ryu H.J.; Seo M.R.; Choi H.J.; Baek H.J.; Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51. Korean J Intern Med (Korean Assoc Intern Med) 2017","journal-title":"Korean J Intern Med (Korean Assoc Intern Med)"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"00013","DOI":"10.15406\/moji.2014.01.00013","volume":"1","author":"Kurata R.","year":"2014","unstructured":"Kurata R.; Yonezawa T.; Inoko H.; Association Analysis of the Polymorphism of Human Leuko-cyte Antigen-A,-B and-E Gene with Behcet\u2019s Disease in Japa-nese Cohort Using Sequencing-Based Typing Method. MOJ Immunol 2014,1(3),00013","journal-title":"MOJ Immunol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/ng.2551","volume":"45","author":"Hughes T.","year":"2013","unstructured":"Hughes T.; Coit P.; Adler A.; Identification of multiple independent susceptibility loci in the HLA region in Beh\u00e7et\u2019s disease. Nat Genet 2013,45(3),319-324","journal-title":"Nat Genet"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1399-0039.2006.00742.x","volume":"69","author":"Park K.S.","year":"2007","unstructured":"Park K.S.; Park J.S.; Nam J.H.; Bang D.; Sohn S.; Lee E.S.; HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet\u2019s disease. Tissue Antigens 2007,69(2),139-144","journal-title":"Tissue Antigens"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.1073\/pnas.1406575111","volume":"111","author":"Ombrello M.J.","year":"2014","unstructured":"Ombrello M.J.; Kirino Y.; de Bakker P.I.; G\u00fcl A.; Kastner D.L.; Remmers E.F.; Beh\u00e7et disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity. Proc Natl Acad Sci USA 2014,111(24),8867-8872","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/ni.3579","volume":"18","author":"Pfeifle R.","year":"2017","unstructured":"Pfeifle R.; Rothe T.; Ipseiz N.; Regulation of autoantibody activity by the IL-23-T17 axis determines the onset of autoimmune disease. Nat Immunol 2017,18(1),104-113","journal-title":"Nat Immunol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.autrev.2015.07.007","volume":"14","author":"Lerner A.","year":"2015","unstructured":"Lerner A.; Matthias T.; Rheumatoid arthritis-celiac disease relationship: joints get that gut feeling. Autoimmun Rev 2015,14(11),1038-1047","journal-title":"Autoimmun Rev"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13075-015-0542-4","volume":"17","author":"Yang Z.","year":"2015","unstructured":"Yang Z.; Matteson E.L.; Goronzy J.J.; Weyand C.M.; T-cell metabolism in autoimmune disease. Arthritis Res Ther 2015,17(1),29","journal-title":"Arthritis Res Ther"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/ard.2007.071662","volume":"67","author":"Karlson E.W.","year":"2008","unstructured":"Karlson E.W.; Chibnik L.B.; Cui J.; Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study. Ann Rheum Dis 2008,67(3),358-363","journal-title":"Ann Rheum Dis"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1086\/342407","volume":"71","author":"Jawaheer D.","year":"2002","unstructured":"Jawaheer D.; Li W.; Graham R.R.; Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet 2002,71(3),585-594","journal-title":"Am J Hum Genet"},{"key":"ref=23","author":"Gonzalez-Gay M.A.","year":"2002","unstructured":"Gonzalez-Gay M.A.; Garcia-Porrua C.; Hajeer A.H.;  Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis seminars in arthritis and rheumatism 2002","journal-title":"Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis seminars in arthritis and rheumatism"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/jhg.2015.36","volume":"60","author":"Furukawa H.","year":"2015","unstructured":"Furukawa H.; Oka S.; Shimada K.; Hashimoto A.; Tohma S.; Human leukocyte antigen polymorphisms and personalized medicine for rheumatoid arthritis. J Hum Genet 2015,60(11),691-696","journal-title":"J Hum Genet"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.it.2003.09.006","volume":"24","author":"Tsao B.P.","year":"2003","unstructured":"Tsao B.P.; The genetics of human systemic lupus erythematosus. Trends Immunol 2003,24(11),595-602","journal-title":"Trends Immunol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jaut.2015.08.004","volume":"64","author":"Ghodke-Puranik Y.","year":"2015","unstructured":"Ghodke-Puranik Y.; Niewold T.B.; Immunogenetics of systemic lupus erythematosus: A comprehensive review. J Autoimmun 2015,64,125-136","journal-title":"J Autoimmun"},{"key":"ref=27","doi-asserted-by":"publisher","DOI":"10.1016\/j.mgene.2018.03.011","author":"Dedhia L.","year":"2018","unstructured":"Dedhia L.; Pradhan V.; Ghosh K.; Nadkar M.; Parekh S.; Association of Human Leucocyte Antigen (HLA) class II with Systemic Lupus Erythematosis (SLE) patients from western India. Meta Gene 2018","journal-title":"Meta Gene"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.humimm.2018.01.005","volume":"79","author":"Gambino C.M.","year":"2018","unstructured":"Gambino C.M.; Di Bona D.; Aiello A.; HLA-C1 ligands are associated with increased susceptibility to systemic lupus erythematosus. Hum Immunol 2018,79(3),172-177","journal-title":"Hum Immunol"},{"key":"ref=29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087792","volume":"9","author":"Furukawa H.","year":"2014","unstructured":"Furukawa H.; Kawasaki A.; Oka S.; Human leukocyte antigens and systemic lupus erythematosus: a protective role for the HLA-DR6 alleles DRB1*13:02 and *14:03. PLoS One 2014,9(2)","journal-title":"PLoS One"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/gene.2014.6","volume":"15","author":"Morris D.L.","year":"2014","unstructured":"Morris D.L.; Fernando M.M.; Taylor K.E.; Systemic lupus erythematosus genetics consortium. MHC associations with clinical and autoantibody manifestations in European SLE. Genes Immun 2014,15(4),210-217","journal-title":"Genes Immun"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jaut.2016.06.017","volume":"74","author":"Cruz G.I.","year":"2016","unstructured":"Cruz G.I.; Shao X.; Quach H.; A Child\u2019s HLA-DRB1 genotype increases maternal risk of systemic lupus erythematosus. J Autoimmun 2016,74,201-207","journal-title":"J Autoimmun"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.humimm.2007.11.001","volume":"69","author":"Rosado S.","year":"2008","unstructured":"Rosado S.; Perez-Chacon G.; Mellor-Pita S.; Expression of human leukocyte antigen-G in systemic lupus erythematosus. Hum Immunol 2008,69(1),9-15","journal-title":"Hum Immunol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1399-0039.1996.tb02512.x","volume":"47","author":"Yasunaga S.","year":"1996","unstructured":"Yasunaga S.; Kimura A.; Hamaguchi K.; R\u00f8nningen K.S.; Sasazuki T.; Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM). Tissue Antigens 1996,47(1),37-48","journal-title":"Tissue Antigens"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.humimm.2004.12.001","volume":"66","author":"Valdes A.M.","year":"2005","unstructured":"Valdes A.M.; Erlich H.A.; Noble J.A.; Human leukocyte antigen class I B and C loci contribute to Type 1 Diabetes (T1D) susceptibility and age at T1D onset. Hum Immunol 2005,66(3),301-313","journal-title":"Hum Immunol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ajpath.2014.09.004","volume":"185","author":"Skog O.","year":"2015","unstructured":"Skog O.; Korsgren S.; Wiberg A.; Expression of human leukocyte antigen class I in endocrine and exocrine pancreatic tissue at onset of type 1 diabetes. Am J Pathol 2015,185(1),129-138","journal-title":"Am J Pathol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1515\/CCLM.2009.346","volume":"47","author":"Lavant E.H.","year":"2009","unstructured":"Lavant E.H.; Carlson J.A.; A new automated human leukocyte antigen genotyping strategy to identify DR-DQ risk alleles for celiac disease and type 1 diabetes mellitus. Clin Chem Lab Med 2009,47(12),1489-1495","journal-title":"Clin Chem Lab Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature22329","volume":"545","author":"Ooi J.D.","year":"2017","unstructured":"Ooi J.D.; Petersen J.; Tan Y.H.; Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells. Nature 2017,545(7653),243-247","journal-title":"Nature"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1073\/pnas.1523482113","volume":"113","author":"Cavalli G.","year":"2016","unstructured":"Cavalli G.; Hayashi M.; Jin Y.; MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo. Proc Natl Acad Sci USA 2016,113(5),1363-1368","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1808850115","author":"Terao C.","unstructured":"Terao C.; Yoshifuji H.; Matsumura T.; Naruse T.K.; Ishii T.; Nakaoka Y.; Genetic determinants and an epistasis of LILRA3 and HLA-B* 52 in Takayasu arteritis. Proceedings of the National Academy of Sciences","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/gene.2014.82","volume":"16","author":"van Gerven N.M.","year":"2015","unstructured":"van Gerven N.M.; de Boer Y.S.; Zwiers A.; HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1. Genes Immun Dutch Autoimmune Hepatitis Study Group2015,16(4),247-252","journal-title":"Genes Immun"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaut.2015.07.009","volume":"64","author":"Lee H.J.","year":"2015","unstructured":"Lee H.J.; Li C.W.; Hammerstad S.S.; Stefan M.; Tomer Y.; Immunogenetics of autoimmune thyroid diseases: A comprehensive review. J Autoimmun 2015,64,82-90","journal-title":"J Autoimmun"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"Antonelli A.","year":"2015","unstructured":"Antonelli A.; Ferrari S.M.; Corrado A.; Di Domenicantonio A.; Fallahi P.; Autoimmune thyroid disorders. Autoimmun Rev 2015,14(2),174-180","journal-title":"Autoimmun Rev"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41435-017-0008-6","author":"Ramgopal S.","year":"2018","unstructured":"Ramgopal S.; Rathika C.; Malini R.P.; Murali V.; Arun K.; Balakrishnan K.; Critical amino acid variations in HLA-DQB1* molecules confers susceptibility to autoimmune thyroid disease in south India. Genes Immun 2018,1","journal-title":"Genes Immun"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.autrev.2016.09.009","volume":"15","author":"Fallahi P.","year":"2016","unstructured":"Fallahi P.; Ferrari S.M.; Ruffilli I.; The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients. Autoimmun Rev 2016,15(12),1125-1128","journal-title":"Autoimmun Rev"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nm.3411","volume":"20","author":"Carbone F.","year":"2014","unstructured":"Carbone F.; De Rosa V.; Carrieri P.B.; Regulatory T cell proliferative potential is impaired in human autoimmune disease. Nat Med 2014,20(1),69-74","journal-title":"Nat Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fimmu.2015.00100","volume":"6","author":"Hayes C.E.","year":"2015","unstructured":"Hayes C.E.; Hubler S.L.; Moore J.R.; Barta L.E.; Praska C.E.; Nashold F.E.; Vitamin D actions on CD T cells in autoimmune disease. Front Immunol 2015,6,100","journal-title":"Front Immunol"},{"key":"ref=47","volume":"19","author":"Gul A.","year":"2001","unstructured":"Gul A.; Behcet's disease: an update on the pathogenesis.  Clinical and experimental rheumatology (5; SUPP\/24): S-6.2001,19","journal-title":"Clinical and experimental rheumatology"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2337\/dc08-0239","volume":"31","author":"Fourlanos S.","year":"2008","unstructured":"Fourlanos S.; Varney M.D.; Tait B.D.; The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 2008,31(8),1546-1549","journal-title":"Diabetes Care"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/science.aad2791","volume":"351","author":"Delong T.","year":"2016","unstructured":"Delong T.; Wiles T.A.; Baker R.L.; Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 2016,351(6274),711-714","journal-title":"Science"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jcp.56.7.481","volume":"56","author":"Mok C.C.","year":"2003","unstructured":"Mok C.C.; Lau C.S.; Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003,56(7),481-490","journal-title":"J Clin Pathol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","volume":"11","author":"Pineton de Chambrun M.","year":"2012","unstructured":"Pineton de Chambrun M.; Wechsler B.; Geri G.; Cacoub P.; Saadoun D.; New insights into the pathogenesis of Beh\u00e7et\u2019s disease. Autoimmun Rev 2012,11(10),687-698","journal-title":"Autoimmun Rev"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T04:34:38Z","timestamp":1576557278000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169006\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,25]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11,25]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573397115666190115143226","relation":{},"ISSN":["1573-3971"],"issn-type":[{"value":"1573-3971","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,25]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-08-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}